[31P magnetic resonance spectroscopy: a noninvasive method for studying skeletal muscle metabolism in patients with arteriosclerosis obliterans of the vessels of the lower extremities and for assessing the efficacy of vasoprostan therapy].
Sinitsyn
V E
VE
Veselova
T N
TN
Bakharev
A O
AO
Karpov
Iu A
IuA
D000527:Alprostadil / Q000627:therapeutic use*; D001162:Arteriosclerosis Obliterans / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism*; D004341:Drug Evaluation; D005080:Exercise Test; D006801:Humans; D007383:Intermittent Claudication / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism; D007866:Leg / Q000098:blood supply*; D009682:Magnetic Resonance Spectroscopy / Q000295:instrumentation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000378:metabolism*
D000527:Alprostadil
31P magnitno-rezonansnaia spektroskopiia: neinvazivnyĭ metod izucheniia metabolizma skeletnykh myshts u bol'nykh obliteriruiushchim aterosklerozom sosudov nizhnikh konechnosteĭ i otsenki éffektivnosti terapii vazoprostanom.